Non-profitUnited Statesproject-sleep.com
None yet. When a new project in the record names Project Sleep as owner, partner or investor, it shows here.
First-in-class oral OX2R agonist for adults with NT1; Phase 3 showed symptom-wide benefit including daytime sleepiness and cataplexy; DEA scheduling pending before distribution.
